| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.162 | 0 | 0 | 0 | 16.787 | 8.133 | 8.605 | 12.062 | 56.191 | 37.877 |
| Total Income - EUR | 47.186 | 0 | 0 | 0 | 21.715 | 8.001 | 8.061 | 14.321 | 40.838 | 31.194 |
| Total Expenses - EUR | 9.369 | 949 | 732 | 3.882 | 20.676 | 5.679 | 6.416 | 10.245 | 19.890 | 25.426 |
| Gross Profit/Loss - EUR | 37.817 | -949 | -732 | -3.882 | 1.039 | 2.321 | 1.645 | 4.075 | 20.948 | 5.768 |
| Net Profit/Loss - EUR | 36.401 | -949 | -732 | -3.882 | 498 | 2.077 | 1.415 | 3.836 | 20.386 | 5.419 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Farmacie Din Străbuni Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 37.293 | 36.109 | 11.914 | 11.995 | 32.281 | 33.301 | 23.514 | 27.150 | 50.840 | 58.359 |
| Inventories | 7.874 | 25.608 | 7.662 | 7.825 | 14.918 | 15.189 | 14.943 | 11.024 | 14.005 | 16.778 |
| Receivables | 3.040 | 3.044 | 1.243 | 3.146 | 16.432 | 15.385 | 6.086 | 11.310 | 33.957 | 40.247 |
| Cash | 26.380 | 7.457 | 3.010 | 1.024 | 931 | 2.728 | 2.485 | 4.817 | 2.878 | 1.334 |
| Shareholders Funds | 37.411 | 36.080 | 13.538 | 9.408 | 9.724 | 11.617 | 12.774 | 16.650 | 35.587 | 40.807 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29 | 29 | -1.624 | 2.587 | 22.557 | 21.685 | 10.739 | 10.500 | 15.283 | 17.552 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Farmacie Din Străbuni Srl